Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cyclization and asymmetric hydrogenation route for Upatinib intermediates. High purity, scalable process reducing manufacturing costs and lead times.
Patent CN112409235B reveals a high-yield synthesis route for chiral 4-halotryptophan derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105111208B enables efficient asymmetric hydrogenation. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113999207B reveals efficient synthesis of pyridyl-containing chiral NNN ligands via asymmetric hydrogenation, offering cost-effective routes for pharmaceutical intermediates.
Patent CN112358379A reveals a high-efficiency asymmetric hydrogenation route for S-1,1-bis(4-fluorophenyl)propan-2-ol, offering superior purity and scalability for florypicoxamid production.
Patent CN109824601B details an iridium-catalyzed asymmetric hydrogenation method for synthesizing chiral cyclic ureas with high enantioselectivity, offering significant supply chain advantages.
Patent CN114436831A reveals a high-yield rhodium-catalyzed asymmetric hydrogenation route for chiral esters, offering significant cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Novel asymmetric hydrogenation method enables high-purity dihydro-9-phenanthrene amine production with enhanced supply chain reliability and cost efficiency for pharmaceutical manufacturing.
Patent CN115872905A enables high-purity API intermediate production with TON=100,000, reducing manufacturing costs and supply chain lead time through green catalysis.
Solve enantioselectivity challenges in asymmetric hydrogenation with tunable bisphosphine ligands. Achieve 92-99% ee, recyclable catalysts, and simplified synthesis for cost-effective API production.
Solve supply chain challenges for (Z)-2-acetylaminocinnamic acid methyl ester with 68%+ yield, 99%+ purity, and no column chromatography. Industrial-scale production ready.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.
Solve racemic drug limitations with 99% ee asymmetric synthesis. Reduce production costs & supply chain risks for topical antifungal manufacturing. Contact for custom synthesis solutions.